Ovarian Cancer
Some facts...
- Cancer is the deadliest gynecologic cancer and the 5th leading cause of cancer deaths among American women. No routine screening test exists to detect Ovarian Cancer.
- 12,810 American women will die from the disease in 2022.
- 19,880 American women will be diagnosed in 2022.
- Only 16% of Ovarian cases are diagnosed at an early stage—when treatment can make a major difference.
"Ovarian Cancer is a killer disease — early detection greatly increases the chance of survival."
The majority of Ovarian Cancers are diagnosed late, after the cancers have spread. Only about 19% of women are diagnosed early, when the disease may be curable. Many people don’t know the symptoms that might indicate Ovarian Cancer in the majority of women who develop the disease.
The problem is that these symptoms are found equally in women without the disease. Nonetheless early recognition of symptoms is the best existing way to save women’s lives. If women have these symptoms for longer than a couple of weeks, they should consult their doctor and express their concern about Ovarian Cancer. Research shows that about 90% of women with early-stage Ovarian Cancer do experience symptoms. Doctors do not know exactly what causes Ovarian Cancer. All women are at risk, however, some factors and conditions may increase a woman’s risk of developing this condition such as age (women over 50 are more likely), a family history of breast or colon cancer, and women who have never given birth. Women need to know if they may be at a higher risk for Ovarian Cancer, and if so, what actions to take. In fact, 90% of women diagnosed do not have a family history that might put them at a higher risk.
Although Ovarian Cancer is less common than breast and cervical cancer, the low five-year survival rate underscores its deadliness. The over-all 5-year survival rate for women diagnosed with Ovarian Cancer is approximately 46%, versus 89% for women diagnosed with beast cancer and 72% for women diagnosed with cervical cancer. Proven tools and methods exist for early detection of breast and cervical cancers. Through scientific advancements, advocacy and education, the breast and cervical cancer communities have dramatically increased the detection of these cancers in their most treatable stages and decreased mortality rates. This is the type of progress and the resources that need to be applied to Ovarian Cancer.
The majority of Ovarian Cancers are found at an advanced stage and there is a critical need for a reliable early screening test because many lives could be saved. The tests that are currently available are: a transvaginal ultrasound which will demonstrate whether the ovaries are abnormal and additional tests needed, and a CA-125 blood test which measures a protein on the ovarian surface. Over 90% of women with advanced Ovarian Cancer will have an elevated CA-125. Women with a close family member or several family members with ovarian, breast, or colorectal cancer or the BRCA1 or BRCA2 or HNPCC gene should discuss their risk factors with their doctor. The run raises money to fund Ovarian Cancer screening programs for uninsured and underinsured women and also funds educational initiatives. These are critical goals, that meet important health issues for woman of all ages.
The problem is that these symptoms are found equally in women without the disease. Nonetheless early recognition of symptoms is the best existing way to save women’s lives. If women have these symptoms for longer than a couple of weeks, they should consult their doctor and express their concern about Ovarian Cancer. Research shows that about 90% of women with early-stage Ovarian Cancer do experience symptoms. Doctors do not know exactly what causes Ovarian Cancer. All women are at risk, however, some factors and conditions may increase a woman’s risk of developing this condition such as age (women over 50 are more likely), a family history of breast or colon cancer, and women who have never given birth. Women need to know if they may be at a higher risk for Ovarian Cancer, and if so, what actions to take. In fact, 90% of women diagnosed do not have a family history that might put them at a higher risk.
Although Ovarian Cancer is less common than breast and cervical cancer, the low five-year survival rate underscores its deadliness. The over-all 5-year survival rate for women diagnosed with Ovarian Cancer is approximately 46%, versus 89% for women diagnosed with beast cancer and 72% for women diagnosed with cervical cancer. Proven tools and methods exist for early detection of breast and cervical cancers. Through scientific advancements, advocacy and education, the breast and cervical cancer communities have dramatically increased the detection of these cancers in their most treatable stages and decreased mortality rates. This is the type of progress and the resources that need to be applied to Ovarian Cancer.
The majority of Ovarian Cancers are found at an advanced stage and there is a critical need for a reliable early screening test because many lives could be saved. The tests that are currently available are: a transvaginal ultrasound which will demonstrate whether the ovaries are abnormal and additional tests needed, and a CA-125 blood test which measures a protein on the ovarian surface. Over 90% of women with advanced Ovarian Cancer will have an elevated CA-125. Women with a close family member or several family members with ovarian, breast, or colorectal cancer or the BRCA1 or BRCA2 or HNPCC gene should discuss their risk factors with their doctor. The run raises money to fund Ovarian Cancer screening programs for uninsured and underinsured women and also funds educational initiatives. These are critical goals, that meet important health issues for woman of all ages.
Signs to look for...• bloating
• pelvic or abdominal pain • difficulty eating or feeling full quickly • urinary symptoms (urgency or frequency) • fatigue • indigestion • pain with intercourse • constipation • back pain and • menstrual irregularities |
There is no definitive screening test for early Ovarian Cancer.
There is no reliable and easy-to-administer test for Ovarian Cancer (as there is for cervical cancer with a Pap smear). Unfortunately less than one-third of Ovarian Cancers are detected before they have spread outside of the ovaries.
|
